phenylacetic acid has been researched along with Acute Promyelocytic Leukemia in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samid, D | 1 |
| Shack, S | 1 |
| Sherman, LT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy[NCT00001565] | Phase 1 | 35 participants | Interventional | 1996-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for phenylacetic acid and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Azacitidine; Cell Differentiation; Cell Division; Ce | 1992 |